MEM

MEMPHASYS FPO [MEM]
Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. The company offers Felix system, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes. It also provides RoXsta, an in-vitro diagnostic device; and AI-Port, an ambient temperature semen transport device for artificial insemination in animals. In addition, the company develops ambient temperature storage product for human sperm; and a medium for human sperm isolation, fertilisation and cryopreservation. Memphasys Limited was incorporated in 2006 and is based in Homebush, Australia.
Healthcare · ASX Small Cap
$0.0060 +0.0%

Updated 9 Sep 2026 · Signals refresh every scan

Appeared in 2 consecutive scansFirst seen: 2026-02-25
Get alerts when MEM triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track MEM — Free

Active Signals

Bullish Signals

  • MACD momentum is picking up steam
  • Volume surging at 6.6x normal while price falls — heavy selling pressure
  • Watch out — volume is flowing out even as price holds up. Distribution pattern
  • Lagging the Small Ords index — relative strength of 0.88, underperforming its peers
  • Trading above the 200-day average — the long-term trend is on your side
  • Critical cash runway (1.9 quarters)
  • Strong revenue growth (+220%)
  • Micro-cap ($5-20M) - high risk
  • Sentiment is mixed — no strong consensus either way
  • Strong long-term momentum — up 75% over the past year (excluding last month)
  • Revenue growing at +220% — the top line is moving in the right direction
  • The bigger volume days are the up days — volume-weighted momentum is positive (1.49%/day)
  • Altman Z-Score grey zone (2.24, low-confidence approx)
  • Penny stock risk ($0.006)
  • RBA hiking (-3pts)

Risk Signals

  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Not enough chatter to gauge sentiment — defaulting to neutral

Expected next for MEM

22 Oct 2026Quarterly Cash Flow Report (4C)Estimated from past filings
Window: 15 Oct to 29 Oct
The last 4 moved MEM -2.8% on the day, on average — an observation, not a guide to what happens next.
Each date is labelled with how it is known. A date estimated from past filings is inferred from this company's own filing rhythm — it is not a confirmed date and not a statement about what the company intends to do. See the whole ASX calendar →

Recent Catalysts

NONE Memphasys Investor Webinar Presentation - September 2026
NONE Investor Webinar Invite
NONE Felix Registration Achieved in Turkey, Sales Commence
Announcement tone +3pts

Recent ASX Announcements

2026-09-07 Memphasys Investor Webinar Presentation - September 2026
2026-09-04 Investor Webinar Invite
2026-09-02 Felix Registration Achieved in Turkey, Sales Commence PRICE SENSITIVE
2026-09-01 Notification of cessation of securities - MEM
2026-08-31 EUR526,500 Nordic Agreement Expands Felix European Footprint PRICE SENSITIVE

Key Metrics

$18.5M
Market Cap
5.2M
Avg Volume
6.6x
Vol Ratio
$0.00 — $0.01
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-95.9%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 61%
LLeader vs LaggardlaggardRS: 0
IInstitutional Sponsorshipinsufficient_dataInst: 0%
MMarket DirectionneutralNeutral

Sector: Healthcare

110 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
NUZ +37.1%IPD +20.0%HIQ +16.7%AVE +15.0%CVB +11.1%
Compare:MEM vs NUZMEM vs IPDMEM vs HIQ
Share this analysis

Track MEM and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required